Other Solid Tumors Terminated Phase 1 / 2 Trials for Rovalpituzumab tesirine (DB13017)

Also known as: Other Solid Tumor

IndicationStatusPhase
DBCOND0030393 (Other Solid Tumors)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02709889Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsTreatment